|
Press Releases |
|
|
|
Wednesday, December 20, 2023 |
|
欧康维视生物: OT-703获批于香港上市,为糖尿病性黄斑水肿患者治疗带来新选择 |
中国领先眼科医药平台公司 — 欧康维视生物(「欧康维视」或「公司」,连同其附属公司,统称「集团」,股份代号:1477)欣然宣布,集团旗下OT-703(ILUVIEN(R),氟轻松玻璃体植入剂) more info >> |
|
歐康維視生物: OT-703獲批於香港上市,為糖尿病性黃斑水腫患者治療帶來新選擇 |
中國領先眼科醫藥平台公司 — 歐康維視生物(「歐康維視」或「公司」,連同其附屬公司,統稱「集團」,股份代號:1477)欣然宣佈,集團旗下OT-703(ILUVIEN(R),氟輕鬆玻璃體植入劑) more info >> |
|
Ocumension Therapeutics: The Approval Received For Marketing OT-703 In Hong Kong, A New Option For Patients With Diabetic Macular Edema |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, is pleased to announce that, OT-703 (ILUVIEN(R), fluocinolone intravitreal implant), an injectable more info >> |
|
Thursday, August 24, 2023 |
|
欧康维视公布2023年中期业绩 |
中国领先眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司,统称「集团」)(股份代号:1477.HK),今天公布截至2023年6月30日止六个月(「报告期内」)中期业绩。 more info >> |
|
歐康維視公佈2023年中期業績 |
中國領先眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司,統稱「集團」)(股份代號:1477.HK),今天公佈截至2023年6月30日止六個月(「報告期內」)中期業績。 more info >> |
|
Ocumension Therapeutics Announces 2023 Interim Results |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, announced its interim results for the six months ended 30 June 2023 ("the Period") today. more info >> |
|
Thursday, March 30, 2023 |
|
欧康维视公布2022年全年业绩 |
中国领先眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司,统称「集团」)(股份代号:1477.HK),今天公布截至2022年12月31日止年度(「年度」)全年业绩。 more info >> |
|
歐康維視公佈2022年全年業績 |
中國領先眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司,統稱「集團」)(股份代號:1477.HK),今天公佈截至2022年12月31日止年度(「年度」)全年業績。 more info >> |
|
Ocumension Therapeutics Announces 2022 Annual Results |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, announced its annual results for the year ended 31 December 2022 today. more info >> |
|
Monday, March 13, 2023 |
|
欧康维视获纳入沪港通及深港通名单 |
中国领先眼科医药平台公司 — 欧康维视生物(「欧康维视」或「公司」,连同其附属公司,统称「集团」,股份代号:1477)欣然宣布,集团在香港联合交易所有限公司(「香港交易所」)发行的普通股正式被纳入港股通下沪港通及深港通股票名单,并于3月13日起生效。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Shaping the Future of Technology with AI Everywhere Take Center Stage at the 13th Big CIO Show
May 10, 2024 20:55 HKT/SGT
|
|
|
DOCOMO to Launch "NTT DOCOMO GLOBAL" for Global Expansion
May 10, 2024 18:13 JST
|
|
|
Japan Energy Summit and Exhibition Hosts and Sponsors Demonstrate the Importance of Accelerating Decarbonisation
May 10, 2024 16:04 HKT/SGT
|
|
|
Pertamina International Shipping (PIS) Welcomes 2 VLGC Tankers to Its Fleet, Takes Top-Tier Position in ASEAN LPG Transport
May 10, 2024 16:00 HKT/SGT
|
|
|
Q2 Metals Announces Assay Results from Its 2024 Winter Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
May 10, 2024 15:09 HKT/SGT
|
|
|
三菱重工など、電力系統の混雑緩和を実現するシステムのフィールド実証を開始
May 10, 2024 11:50: JST
|
|
|
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 10, 2024 12:20 JST
|
|
|
InfoComm Asia 2024 "Asia's International Pro AV Exhibition" Returns to Thailand
May 10, 2024 10:30 HKT/SGT
|
|
|
BLUETTI Unlocks Special Mother's Day Offerings, Perfect Gift Ideas for Moms
May 10, 2024 10:00 HKT/SGT
|
|
|
AGILON HEALTH (NYSE: AGL) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Agilon Health Investors of a Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:33 HKT/SGT
|
|
|
SSR MINING (SSRM) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies SSR Mining Investors of a Class Action Lawsuit and May 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:26 HKT/SGT
|
|
|
CHEMOURS (NYSE: CC) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:20 HKT/SGT
|
|
|
DOXIMITY (NYSE: DOCS) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and June 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:13 HKT/SGT
|
|
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|